欧林生物：2025年净利润2223.17万元，同比增长7.10%

Core Viewpoint - The company reported a revenue of 704 million yuan for the fiscal year 2025, marking a year-on-year growth of 19.58%, alongside a net profit of 22.23 million yuan, which represents a 7.10% increase compared to the previous year [1] Group 1 - The company has strengthened its market promotion efforts during the reporting period [1] - Sales of the tetanus vaccine have shown steady growth [1]